{"entity":{"type":"insider","cik":"0001413350","url":"/insider/0001413350","json_url":"/insider/0001413350.json","name":"Venkatesan Jay","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":22,"n_filings":17,"first":"2007-10-17","last":"2026-06-22","span_basis":"filed_date"},"name_variants":[{"name":"Venkatesan Jay","source":"filing","n_filings":17,"first_seen":"2007-10-17","last_seen":"2026-06-22"}],"transactions":[{"id":6091766,"accession":"0001413350-26-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001413350-26-000004","line_url":"/filing/0001413350-26-000004#line-1","is_derivative":false,"issuer_cik":"0001413350","issuer_name":"Serina Therapeutics, Inc.","issuer_ticker":"SER","issuer_name_source":null,"issuer_url":"/issuer/0001413350","owner_cik":"0001413350","owner_name":"Venkatesan Jay","owner_display_name":"Venkatesan Jay","owner_url":"/insider/0001413350","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":589.0,"shares_display":"589","price_per_share":1.78,"price_display":"1.78","price_state":"stated","total_value":1048.42,"total_display":"1,048.42","total_whole":"1,048","shares_owned_after":589.0,"shares_owned_after_display":"589","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-22","filed_date":"2026-06-22","scope":"insider"},{"id":6102981,"accession":"0001601485-22-000043","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601485-22-000043","line_url":"/filing/0001601485-22-000043#line-1","is_derivative":false,"issuer_cik":"0001413350","issuer_name":"Angion Biomedica Corp.","issuer_ticker":"ANGN","issuer_name_source":null,"issuer_url":"/issuer/0001413350","owner_cik":"0001413350","owner_name":"Venkatesan Jay","owner_display_name":"Venkatesan Jay","owner_url":"/insider/0001413350","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11313.0,"shares_display":"11,313","price_per_share":1.2466,"price_display":"1.25","price_state":"stated","total_value":14102.7858,"total_display":"14,102.79","total_whole":"14,103","shares_owned_after":1891947.0,"shares_owned_after_display":"1,891,947","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-25","filed_date":"2022-05-27","scope":"insider"},{"id":6499110,"accession":"0001601485-22-000039","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001601485-22-000039","line_url":"/filing/0001601485-22-000039#line-2","is_derivative":false,"issuer_cik":"0001413350","issuer_name":"Angion Biomedica Corp.","issuer_ticker":"ANGN","issuer_name_source":null,"issuer_url":"/issuer/0001413350","owner_cik":"0001413350","owner_name":"Venkatesan Jay","owner_display_name":"Venkatesan Jay","owner_url":"/insider/0001413350","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":32200.0,"shares_display":"32,200","price_per_share":1.24,"price_display":"1.24","price_state":"stated","total_value":39928.0,"total_display":"39,928.00","total_whole":"39,928","shares_owned_after":1721457.0,"shares_owned_after_display":"1,721,457","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-24","filed_date":"2022-05-25","scope":"insider"},{"id":6499108,"accession":"0001601485-22-000039","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601485-22-000039","line_url":"/filing/0001601485-22-000039#line-1","is_derivative":false,"issuer_cik":"0001413350","issuer_name":"Angion Biomedica Corp.","issuer_ticker":"ANGN","issuer_name_source":null,"issuer_url":"/issuer/0001413350","owner_cik":"0001413350","owner_name":"Venkatesan Jay","owner_display_name":"Venkatesan Jay","owner_url":"/insider/0001413350","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":1.23,"price_display":"1.23","price_state":"stated","total_value":61500.0,"total_display":"61,500.00","total_whole":"61,500","shares_owned_after":1689257.0,"shares_owned_after_display":"1,689,257","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-20","filed_date":"2022-05-25","scope":"insider"},{"id":4391860,"accession":"0001601485-21-000095","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001601485-21-000095","line_url":"/filing/0001601485-21-000095#line-2","is_derivative":false,"issuer_cik":"0001413350","issuer_name":"Angion Biomedica Corp.","issuer_ticker":"ANGN","issuer_name_source":null,"issuer_url":"/issuer/0001413350","owner_cik":"0001413350","owner_name":"Venkatesan Jay","owner_display_name":"Venkatesan Jay","owner_url":"/insider/0001413350","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":210337.0,"shares_display":"210,337","price_per_share":2.6617,"price_display":"2.66","price_state":"stated","total_value":559853.9929,"total_display":"559,853.99","total_whole":"559,854","shares_owned_after":1639257.0,"shares_owned_after_display":"1,639,257","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-28","filed_date":"2021-12-29","scope":"insider"},{"id":4391857,"accession":"0001601485-21-000095","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601485-21-000095","line_url":"/filing/0001601485-21-000095#line-1","is_derivative":false,"issuer_cik":"0001413350","issuer_name":"Angion Biomedica Corp.","issuer_ticker":"ANGN","issuer_name_source":null,"issuer_url":"/issuer/0001413350","owner_cik":"0001413350","owner_name":"Venkatesan Jay","owner_display_name":"Venkatesan Jay","owner_url":"/insider/0001413350","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":66907.0,"shares_display":"66,907","price_per_share":2.5486,"price_display":"2.55","price_state":"stated","total_value":170519.1802,"total_display":"170,519.18","total_whole":"170,519","shares_owned_after":1428920.0,"shares_owned_after_display":"1,428,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-27","filed_date":"2021-12-29","scope":"insider"},{"id":5338379,"accession":"0001601485-21-000093","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601485-21-000093","line_url":"/filing/0001601485-21-000093#line-1","is_derivative":false,"issuer_cik":"0001413350","issuer_name":"Angion Biomedica Corp.","issuer_ticker":"ANGN","issuer_name_source":null,"issuer_url":"/issuer/0001413350","owner_cik":"0001413350","owner_name":"Venkatesan Jay","owner_display_name":"Venkatesan Jay","owner_url":"/insider/0001413350","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3527.0,"shares_display":"3,527","price_per_share":2.5449,"price_display":"2.54","price_state":"stated","total_value":8975.8623,"total_display":"8,975.86","total_whole":"8,976","shares_owned_after":1362013.0,"shares_owned_after_display":"1,362,013","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-20","filed_date":"2021-12-22","scope":"insider"},{"id":4431721,"accession":"0001601485-21-000089","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001601485-21-000089","line_url":"/filing/0001601485-21-000089#line-2","is_derivative":false,"issuer_cik":"0001413350","issuer_name":"Angion Biomedica Corp.","issuer_ticker":"ANGN","issuer_name_source":null,"issuer_url":"/issuer/0001413350","owner_cik":"0001413350","owner_name":"Venkatesan Jay","owner_display_name":"Venkatesan Jay","owner_url":"/insider/0001413350","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13742.0,"shares_display":"13,742","price_per_share":2.5439,"price_display":"2.54","price_state":"stated","total_value":34958.2738,"total_display":"34,958.27","total_whole":"34,958","shares_owned_after":1358486.0,"shares_owned_after_display":"1,358,486","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-17","filed_date":"2021-12-20","scope":"insider"},{"id":4431710,"accession":"0001601485-21-000089","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601485-21-000089","line_url":"/filing/0001601485-21-000089#line-1","is_derivative":false,"issuer_cik":"0001413350","issuer_name":"Angion Biomedica Corp.","issuer_ticker":"ANGN","issuer_name_source":null,"issuer_url":"/issuer/0001413350","owner_cik":"0001413350","owner_name":"Venkatesan Jay","owner_display_name":"Venkatesan Jay","owner_url":"/insider/0001413350","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":27883.0,"shares_display":"27,883","price_per_share":2.5461,"price_display":"2.55","price_state":"stated","total_value":70992.9063,"total_display":"70,992.91","total_whole":"70,993","shares_owned_after":1344744.0,"shares_owned_after_display":"1,344,744","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-16","filed_date":"2021-12-20","scope":"insider"},{"id":4945473,"accession":"0001601485-21-000087","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001601485-21-000087","line_url":"/filing/0001601485-21-000087#line-2","is_derivative":false,"issuer_cik":"0001413350","issuer_name":"Angion Biomedica Corp.","issuer_ticker":"ANGN","issuer_name_source":null,"issuer_url":"/issuer/0001413350","owner_cik":"0001413350","owner_name":"Venkatesan Jay","owner_display_name":"Venkatesan Jay","owner_url":"/insider/0001413350","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":77604.0,"shares_display":"77,604","price_per_share":2.4091,"price_display":"2.41","price_state":"stated","total_value":186955.7964,"total_display":"186,955.80","total_whole":"186,956","shares_owned_after":1316861.0,"shares_owned_after_display":"1,316,861","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-15","filed_date":"2021-12-17","scope":"insider"},{"id":5532766,"accession":"0001626199-21-000113","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001626199-21-000113","line_url":"/filing/0001626199-21-000113#line-1","is_derivative":false,"issuer_cik":"0001413350","issuer_name":"ALPINE IMMUNE SCIENCES, INC.","issuer_ticker":"ALPN","issuer_name_source":null,"issuer_url":"/issuer/0001413350","owner_cik":"0001413350","owner_name":"Venkatesan Jay","owner_display_name":"Venkatesan Jay","owner_url":"/insider/0001413350","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400000.0,"shares_display":"400,000","price_per_share":9.4,"price_display":"9.40","price_state":"stated","total_value":3760000.0,"total_display":"3,760,000.00","total_whole":"3,760,000","shares_owned_after":2600980.0,"shares_owned_after_display":"2,600,980","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-17","filed_date":"2021-09-21","scope":"insider"},{"id":9292966,"accession":"0001601485-22-000045","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001601485-22-000045","line_url":"/filing/0001601485-22-000045#line-1","is_derivative":false,"issuer_cik":"0001601485","issuer_name":"Angion Biomedica Corp.","issuer_ticker":"ANGN","issuer_name_source":null,"issuer_url":"/issuer/0001601485","owner_cik":"0001413350","owner_name":"Venkatesan Jay","owner_display_name":"Venkatesan Jay","owner_url":"/insider/0001413350","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":159177.0,"shares_display":"159,177","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":2546832.0,"total_display":"2,546,832.00","total_whole":"2,546,832","shares_owned_after":1367263.0,"shares_owned_after_display":"1,367,263","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-09","filed_date":"2022-05-27","scope":"insider"},{"id":5107564,"accession":"0001567619-21-003193","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001567619-21-003193","line_url":"/filing/0001567619-21-003193#line-4","is_derivative":false,"issuer_cik":"0001413350","issuer_name":"Angion Biomedica Corp.","issuer_ticker":"ANGN","issuer_name_source":null,"issuer_url":"/issuer/0001413350","owner_cik":"0001413350","owner_name":"Venkatesan Jay","owner_display_name":"Venkatesan Jay","owner_url":"/insider/0001413350","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":159177.0,"shares_display":"159,177","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":2546832.0,"total_display":"2,546,832.00","total_whole":"2,546,832","shares_owned_after":1208086.0,"shares_owned_after_display":"1,208,086","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-09","filed_date":"2021-02-11","scope":"insider"},{"id":8489865,"accession":"0001698530-19-000111","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001698530-19-000111","line_url":"/filing/0001698530-19-000111#line-1","is_derivative":false,"issuer_cik":"0001413350","issuer_name":"EXICURE, INC.","issuer_ticker":"XCUR","issuer_name_source":null,"issuer_url":"/issuer/0001413350","owner_cik":"0001413350","owner_name":"Venkatesan Jay","owner_display_name":"Venkatesan Jay","owner_url":"/insider/0001413350","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":2.0,"price_display":"2.00","price_state":"stated","total_value":500000.0,"total_display":"500,000.00","total_whole":"500,000","shares_owned_after":302234.0,"shares_owned_after_display":"302,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-02","filed_date":"2019-08-06","scope":"insider"},{"id":7775214,"accession":"0000899243-19-001661","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-001661","line_url":"/filing/0000899243-19-001661#line-1","is_derivative":false,"issuer_cik":"0001413350","issuer_name":"ALPINE IMMUNE SCIENCES, INC.","issuer_ticker":"ALPN","issuer_name_source":null,"issuer_url":"/issuer/0001413350","owner_cik":"0001413350","owner_name":"Venkatesan Jay","owner_display_name":"Venkatesan Jay","owner_url":"/insider/0001413350","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":190875.0,"shares_display":"190,875","price_per_share":5.37,"price_display":"5.37","price_state":"stated","total_value":1024998.75,"total_display":"1,024,998.75","total_whole":"1,024,999","shares_owned_after":3994781.0,"shares_owned_after_display":"3,994,781","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-01-18","filed_date":"2019-01-22","scope":"insider"},{"id":5114052,"accession":"0000899243-17-022826","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-17-022826","line_url":"/filing/0000899243-17-022826#line-4","is_derivative":false,"issuer_cik":"0001413350","issuer_name":"Max-1 Acquisition Corp","issuer_ticker":"XCUR","issuer_name_source":null,"issuer_url":"/issuer/0001413350","owner_cik":"0001413350","owner_name":"Venkatesan Jay","owner_display_name":"Venkatesan Jay","owner_url":"/insider/0001413350","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":66666.0,"shares_display":"66,666","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":199998.0,"total_display":"199,998.00","total_whole":"199,998","shares_owned_after":156858.0,"shares_owned_after_display":"156,858","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-09-26","filed_date":"2017-09-28","scope":"insider"},{"id":9269181,"accession":"0001209191-14-059877","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-059877","line_url":"/filing/0001209191-14-059877#line-1","is_derivative":false,"issuer_cik":"0001412067","issuer_name":"Oncothyreon Inc.","issuer_ticker":"ONTY","issuer_name_source":null,"issuer_url":"/issuer/0001412067","owner_cik":"0001413350","owner_name":"Venkatesan Jay","owner_display_name":"Venkatesan Jay","owner_url":"/insider/0001413350","role":"Officer (EVP and General Manager)","role_mark":"O","role_mark_label":"Officer (EVP and General Manager)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and General Manager","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":2.0,"price_display":"2.00","price_state":"stated","total_value":500000.0,"total_display":"500,000.00","total_whole":"500,000","shares_owned_after":250000.0,"shares_owned_after_display":"250,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-09-23","filed_date":"2014-09-26","scope":"insider"},{"id":3497184,"accession":"0001140361-12-031724","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-12-031724","line_url":"/filing/0001140361-12-031724#line-2","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ACCESS PHARMACEUTICALS INC","issuer_ticker":"ACCP","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":null,"owner_name":"Ayer Capital Partners, LLC; Ayer Capital Management, LP; Venkatesan Jay; ACM Capital Partners, LLC","owner_display_name":"Ayer Capital Partners, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":179157.0,"shares_display":"179,157","price_per_share":0.553,"price_display":"0.55","price_state":"stated","total_value":99073.821,"total_display":"99,073.82","total_whole":"99,074","shares_owned_after":2413163.0,"shares_owned_after_display":"2,413,163","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-06-29","filed_date":"2012-06-29","scope":"insider"},{"id":3497180,"accession":"0001140361-12-031724","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-12-031724","line_url":"/filing/0001140361-12-031724#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ACCESS PHARMACEUTICALS INC","issuer_ticker":"ACCP","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":null,"owner_name":"Ayer Capital Partners, LLC; Ayer Capital Management, LP; Venkatesan Jay; ACM Capital Partners, LLC","owner_display_name":"Ayer Capital Partners, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":0.675,"price_display":"0.68","price_state":"stated","total_value":16875.0,"total_display":"16,875.00","total_whole":"16,875","shares_owned_after":2592320.0,"shares_owned_after_display":"2,592,320","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-06-28","filed_date":"2012-06-29","scope":"insider"},{"id":2262373,"accession":"0001140361-12-025869","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-12-025869","line_url":"/filing/0001140361-12-025869#line-2","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ACCESS PHARMACEUTICALS INC","issuer_ticker":"ACCP","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":null,"owner_name":"ACM Capital Partners, LLC; Ayer Capital Management, LP; Ayer Capital Partners, LLC; Venkatesan Jay","owner_display_name":"ACM Capital Partners, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":140300.0,"shares_display":"140,300","price_per_share":0.67,"price_display":"0.67","price_state":"stated","total_value":94001.0,"total_display":"94,001.00","total_whole":"94,001","shares_owned_after":2617320.0,"shares_owned_after_display":"2,617,320","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-05-16","filed_date":"2012-05-16","scope":"insider"},{"id":2262368,"accession":"0001140361-12-025869","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-12-025869","line_url":"/filing/0001140361-12-025869#line-1","is_derivative":false,"issuer_cik":"0000318306","issuer_name":"ACCESS PHARMACEUTICALS INC","issuer_ticker":"ACCP","issuer_name_source":null,"issuer_url":"/issuer/0000318306","owner_cik":null,"owner_name":"ACM Capital Partners, LLC; Ayer Capital Management, LP; Ayer Capital Partners, LLC; Venkatesan Jay","owner_display_name":"ACM Capital Partners, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":0.85,"price_display":"0.85","price_state":"stated","total_value":850.0,"total_display":"850.00","total_whole":"850","shares_owned_after":2757620.0,"shares_owned_after_display":"2,757,620","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-05-15","filed_date":"2012-05-16","scope":"insider"},{"id":7531745,"accession":"0001181431-07-062699","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-07-062699","line_url":"/filing/0001181431-07-062699#line-2","is_derivative":false,"issuer_cik":"0001398161","issuer_name":"Targanta Therapeutics Corp.","issuer_ticker":"TARG","issuer_name_source":null,"issuer_url":"/issuer/0001398161","owner_cik":"0001413350","owner_name":"Venkatesan Jay","owner_display_name":"Venkatesan Jay","owner_url":"/insider/0001413350","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":575000.0,"shares_display":"575,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":5750000.0,"total_display":"5,750,000.00","total_whole":"5,750,000","shares_owned_after":2667987.0,"shares_owned_after_display":"2,667,987","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-10-15","filed_date":"2007-10-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":18,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":15,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":18},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001708599","name":"Serina Therapeutics, Inc.","url":"/issuer/0001708599","role":"Director","n_filings":1,"first_seen":"2026-06-22","last_seen":"2026-06-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001601485","name":"Angion Biomedica Corp.","url":"/issuer/0001601485","role":"Director, Officer","n_filings":8,"first_seen":"2021-02-11","last_seen":"2022-05-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001626199","name":"ALPINE IMMUNE SCIENCES, INC.","url":"/issuer/0001626199","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2019-01-22","last_seen":"2021-09-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001698530","name":"EXICURE, INC.","url":"/issuer/0001698530","role":"Director","n_filings":2,"first_seen":"2017-09-28","last_seen":"2019-08-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001412067","name":"Oncothyreon Inc.","url":"/issuer/0001412067","role":"Officer (EVP and General Manager)","n_filings":1,"first_seen":"2014-09-26","last_seen":"2014-09-26"},{"type":"issuer","type_label":"ISSUER","cik":"0000318306","name":"ACCESS PHARMACEUTICALS INC","url":"/issuer/0000318306","role":"Ten percent owner","n_filings":2,"first_seen":"2012-05-16","last_seen":"2012-06-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001398161","name":"Targanta Therapeutics Corp.","url":"/issuer/0001398161","role":"Director","n_filings":1,"first_seen":"2007-10-17","last_seen":"2007-10-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001413350","retrieved_at":"2026-08-26T07:50:39+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}